Critical mutations in the RAS (rat sarcoma virus) oncogene superfamily, particularly the KRAS gene, play a pivotal role in lung adenocarcinoma initiation, progression, and tumor resistance [29,30]. This evidence concerns the gene KRAS and lung adenocarcinoma.